This document discusses different types of receptors and their mechanisms of action. It describes four main types of receptors: G-protein coupled receptors (GPCRs), ion channel receptors, transmembrane receptors, and nuclear receptors. For each receptor type, it provides examples and explains their signal transduction pathways. Key points covered include GPCR effector mechanisms through G proteins, second messengers like cAMP and IP3, and downstream effects. The document also discusses various ion channels like voltage-gated and receptor-operated channels, as well as receptors for neurotransmitters and hormones.
Role of nuclicacid microarray &protein micro array for drug discovery processmohamed abusalih
role of nuclic acid microarray and protein microarray for drug discovery process
1.introduction about microarray technique and genomics
2.process of drug discovery
3.microarray techiques
4.microarray analysis in drug discovery
5.steps involved in the micro array analysis
SAR versus QSAR, History and development of QSAR, Types of physicochemical
parameters, experimental and theoretical approaches for the determination of
physicochemical parameters such as Partition coefficient, Hammet’s substituent
constant and Taft’s steric constant. Hansch analysis, Free Wilson analysis, 3D-QSAR
approaches like COMFA and COMSIA.
Role of nuclicacid microarray &protein micro array for drug discovery processmohamed abusalih
role of nuclic acid microarray and protein microarray for drug discovery process
1.introduction about microarray technique and genomics
2.process of drug discovery
3.microarray techiques
4.microarray analysis in drug discovery
5.steps involved in the micro array analysis
SAR versus QSAR, History and development of QSAR, Types of physicochemical
parameters, experimental and theoretical approaches for the determination of
physicochemical parameters such as Partition coefficient, Hammet’s substituent
constant and Taft’s steric constant. Hansch analysis, Free Wilson analysis, 3D-QSAR
approaches like COMFA and COMSIA.
Safety pharmacology is a branch of pharmacology with its aim to predict the potential clinical risk profile of new chemical entities (NCEs).
It has the ability to predict the potential off-target drug effects on major organ systems which are associated with exposure in the therapeutic range and above.
As an essential part of the spectrum of drug discovery and development, safety pharmacology studies are generally conducted to determine the relative drug effect on main organs, including respiratory system, central nervous system, and cardiovascular system.Safety pharmacology is an essential part of the drug development process that aims to identify and predict adverse effects prior to clinical trials.
SP studies are described in the international conference on harmonization (ICH) S7A and S7B Guidelines.
A QSAR is a mathematical relationship between a biological activity of a molecular system and its geometric and chemical characteristics.
QSAR attempts to find consistent relationship between biological activity and molecular properties, so that these “rules” can be used to evaluate the activity of new compounds.
Introduction to chronology, chronotherapy, and chronopharmacology.
How chronopharmacology involved in asthma and helps to manage asthma?.
Biological rhythms in bronchial asthma.
Factors associated with nocturnal exacerbation of bronchial asthma.
Introduction to asthma and their symptoms.
Introduction to Antiasthmatic drugs like beta-blockers, leukotriene antagonists, steroids, etc.
Chronopharmacology division & their examples.
Advantages and disadvantages of chronopharmacology.
Marketed preparation and their images along with the price in India.
Safety pharmacology is a branch of pharmacology with its aim to predict the potential clinical risk profile of new chemical entities (NCEs).
It has the ability to predict the potential off-target drug effects on major organ systems which are associated with exposure in the therapeutic range and above.
As an essential part of the spectrum of drug discovery and development, safety pharmacology studies are generally conducted to determine the relative drug effect on main organs, including respiratory system, central nervous system, and cardiovascular system.Safety pharmacology is an essential part of the drug development process that aims to identify and predict adverse effects prior to clinical trials.
SP studies are described in the international conference on harmonization (ICH) S7A and S7B Guidelines.
A QSAR is a mathematical relationship between a biological activity of a molecular system and its geometric and chemical characteristics.
QSAR attempts to find consistent relationship between biological activity and molecular properties, so that these “rules” can be used to evaluate the activity of new compounds.
Introduction to chronology, chronotherapy, and chronopharmacology.
How chronopharmacology involved in asthma and helps to manage asthma?.
Biological rhythms in bronchial asthma.
Factors associated with nocturnal exacerbation of bronchial asthma.
Introduction to asthma and their symptoms.
Introduction to Antiasthmatic drugs like beta-blockers, leukotriene antagonists, steroids, etc.
Chronopharmacology division & their examples.
Advantages and disadvantages of chronopharmacology.
Marketed preparation and their images along with the price in India.
Biological screening of herbal drugs: Introduction and Need for
Phyto-Pharmacological Screening, New Strategies for evaluating
Natural Products, In vitro evaluation techniques for Antioxidants, Antimicrobial and Anticancer drugs. In vivo evaluation techniques
for Anti-inflammatory, Antiulcer, Anticancer, Wound healing, Antidiabetic, Hepatoprotective, Cardio protective, Diuretics and
Antifertility, Toxicity studies as per OECD guidelines
A Strategic Approach: GenAI in EducationPeter Windle
Artificial Intelligence (AI) technologies such as Generative AI, Image Generators and Large Language Models have had a dramatic impact on teaching, learning and assessment over the past 18 months. The most immediate threat AI posed was to Academic Integrity with Higher Education Institutes (HEIs) focusing their efforts on combating the use of GenAI in assessment. Guidelines were developed for staff and students, policies put in place too. Innovative educators have forged paths in the use of Generative AI for teaching, learning and assessments leading to pockets of transformation springing up across HEIs, often with little or no top-down guidance, support or direction.
This Gasta posits a strategic approach to integrating AI into HEIs to prepare staff, students and the curriculum for an evolving world and workplace. We will highlight the advantages of working with these technologies beyond the realm of teaching, learning and assessment by considering prompt engineering skills, industry impact, curriculum changes, and the need for staff upskilling. In contrast, not engaging strategically with Generative AI poses risks, including falling behind peers, missed opportunities and failing to ensure our graduates remain employable. The rapid evolution of AI technologies necessitates a proactive and strategic approach if we are to remain relevant.
Francesca Gottschalk - How can education support child empowerment.pptxEduSkills OECD
Francesca Gottschalk from the OECD’s Centre for Educational Research and Innovation presents at the Ask an Expert Webinar: How can education support child empowerment?
Introduction to AI for Nonprofits with Tapp NetworkTechSoup
Dive into the world of AI! Experts Jon Hill and Tareq Monaur will guide you through AI's role in enhancing nonprofit websites and basic marketing strategies, making it easy to understand and apply.
Embracing GenAI - A Strategic ImperativePeter Windle
Artificial Intelligence (AI) technologies such as Generative AI, Image Generators and Large Language Models have had a dramatic impact on teaching, learning and assessment over the past 18 months. The most immediate threat AI posed was to Academic Integrity with Higher Education Institutes (HEIs) focusing their efforts on combating the use of GenAI in assessment. Guidelines were developed for staff and students, policies put in place too. Innovative educators have forged paths in the use of Generative AI for teaching, learning and assessments leading to pockets of transformation springing up across HEIs, often with little or no top-down guidance, support or direction.
This Gasta posits a strategic approach to integrating AI into HEIs to prepare staff, students and the curriculum for an evolving world and workplace. We will highlight the advantages of working with these technologies beyond the realm of teaching, learning and assessment by considering prompt engineering skills, industry impact, curriculum changes, and the need for staff upskilling. In contrast, not engaging strategically with Generative AI poses risks, including falling behind peers, missed opportunities and failing to ensure our graduates remain employable. The rapid evolution of AI technologies necessitates a proactive and strategic approach if we are to remain relevant.
Read| The latest issue of The Challenger is here! We are thrilled to announce that our school paper has qualified for the NATIONAL SCHOOLS PRESS CONFERENCE (NSPC) 2024. Thank you for your unwavering support and trust. Dive into the stories that made us stand out!
2. .
• CELLULAR MACROMOLECULAR COMPLEX WITH
WHICH ITHE DRUG INTERACTS TO ELICIT A
CELLULAR RESPONSE.
• DRUGS CAN ACT EXTRACELLULAR, CELLULAR AND
INTRACELLULAR.
RECEPTOR
• RECEPTOR - DRUG COMPLEX -EFFECTOR PROTEIN -
SIGNAL TRANSDUCTIONSMECHANISM
• AFFINITY ; INTRINSIC ACTIVITY OR EFFICACY
• AGONIST ; ANTAGONIST
• PARTIAL AGONIST ; INVERSE AGONIST
TERMS
3.
4. TYPES OF RECEPTORS
1) G-PROTEIN COUPLED RECEPTORS (GPCR)
2) ION CHANNEL RECEPTORS - VOC AND ROC.
3) TRANS MEMBRANE RECEPTORS- RECEPTOR TYROSINE KINASES ;
JAK- STAT; SERINE-THREONINE;
TOLL-LIKE; TNF-α
cGMP RECEPTORS
4) NUCLEAR RECEPTORS - CYTOSOLIC AND NUCLEAR
5. G PROTEIN COUPLED
RECEPTORS(METABOTROPIC)
• 7 ALPHA HELICAL PROTEIN WITH
2 DOMAINS
• HETEROTRIMERIC MOLECULE- α,
β, ¥ SUBUNITS TIGHTLY BOUND
TOGETHER WHICH OCCURS IN
RESTING STATE
• EFFECTOR MECHANISMS
7. GS: ADENYLYL CYCLASE ACTIVATION, Ca
CHANNEL OPENING
Gi: ADENYLYL CYCLASE INHIBITON, K+
CHANNEL OPENING
Go: Ca CHANNEL INHIBITION
Gq: PHOSPHOLIPASE- C ACTIVATION- IP3
AND DAG.
GPCR
8. CYCLIC AMP
• IS A PROTOTYPE SECOND MESSENGER FROM ADENYLYL CYCLASE.
• cAMP INCREASED IN GS AND cAMP DECREASED IN Gi PATHWAYS.
WHEN LIGAND(Adrenaline) BINDS TO GPCR,
↓
GS-α +GTP
↓
ACTIVATES ADENYLYL CYCLASE
↓
CAMP IS FORMED
↓
PHOSPHOKINASE A
PHOSPHOKINASE A - PHOSPHORYLATES AND ALTERS THE FUNCTION OF MANY ENYMES, ION
CHANNELS, TRANSPORTERS, TRANSCRIPTION FACTORS, STRUCTURAL PROTEINS.
9.
10. • β¥ DIMER- CAN REGULATE ION CHANNELS, PI3
KINASE
• cAMP FUNCTIONS:
a) cAMP RESPONSE ELEMENT BINDING PROTEIN
b) CYCLIC NUCLEOTIDE GATED CA2+CHANNEL,
PDES,SEVERAL ABC TRANSPORTERS MRP4 AND MRP5.
c) REGULATES GUANINE NUCLEOTIDE EXCHANGE
FACTORS (EPAC)
• TERMINATION - BY PDES INTRACELLULARLY BY PDE3
AND PDE4. WHEREAS CGMP BY PDE5.
11. PHOSPHOLIPASE C (PLC)
ACTIVATED GTP WITH Gq-α SUBUNIT
↓
PIP2 PHOSPHORYLATION BY PLC
↓
SECOND MESSENGERS IP3 AND DAG
↓
DAG REMAINS IN MEMBRANE
;ACTIVATES PKC ALONG WITH ↓
Ca2+.
IP3 MOBILISES Ca2+ FROM ER→Ca-
CALMODULIN COMPLEX→EFFECTS→MLCK
AND CCPK.
12. PL-C HAS 2 ISOFORMS
PLC-βACTIVATED BY GPCR
PLC-¥ACTIVATED BY TYROSINE
PHOSPHORYLATION
13. ION CHANNELS
ACTIVATED G- PROTEIN OPEN OR INHIBIT Ca OR K CHANNELS
WITHOUT SECOND MESSENGERS.
eg: M2 RECEPTORS IN CARDIAC - ↑ K+ PERMEABILITY.
OPIODS REDUCE NEURONAL EXCITABILTY- K+ OPENING
MUSCARINIC M1,M3, M5
M2, M4
Gq
Gi,Go
ADRENERGIC ɑ1
ɑ2
β
Gq
Gi,Go
Gs
DOPAMINE D1
D2
Gs
Gi,Go
SEROTONIN 5HT1
5HT2
Gi,Go
Gq
15. VOC ROC
• MODULATED BY ALTERATIONS IN
VOLTAGE GRADIENT
• 3 STATES: OPEN
CLOSED/BLOCKED
INACTIVATED/REFRACTORY
eg: Na+ channel; K +channel; Ca2+
channel
• CHANNEL WITH A RECEPTOR
SITE
• ROC HAS 2 STATES - OPEN
CLOSED
eg: nicotinic Ach, Glutamate,
5HT3,GABA & Glycine
ION CHANNELS
18. Ca 2+ CHANNEL
• WHEN MEMBRANE IS
DEPOLARISED -40mv
• 5 TYPES L , T , N, P & Q
CHANNELS
• L- TYPE CHANNEL ARE
BLOCKED BY CCBs.
19. K + CHANNEL
β
VOC K+
channel
• vascular and
smooth muscle
• opens when
membrane is
depolarised.
Ca2+ activated
K+ channel
• intracellular
ca2+increases , k+
influx-
repolarisation
• 5HT ,Ach ,NE
ATP sensitive
K+ channel
• cardiac muscle ,
beta cells of
pancreas.
• blocked by SUFI-
INSULIN release
by depolarisation.
20. Receptor Gated Channel:(ROC)
• LIGANDS- EXCITATORY NT-
Ach; Glutamate.
• INHIBITORY NT-
Glycine;GABA
• MAJORITY OF SYNAPSES IN
CNS &ANS.
• MEMBERS OF KV FAMILY
• cAMP GATED (HCN)
CHANNEL IN HEART
• CNG CHANNEL FOR VISION
• K ATP SENSITIVE CHANNEL IN
β CELLS OF PANCREAS -
INSULIN RELEASE BY
SULFONYLUREAS &
MEGLITINIDES.
• 5HT3
ANTAGONIST(ONDANSETR
ON) ON AFFERENT VAGAL
NERVES-
21. Insulin release
ATP INCREASE
BLOCKS K+
CHANNELS- WITH
SUBUNITS Kir6.2
and SUR1 WHICH
CAUSES CA2+
MEDIATED
EXOCYTOSIS OF
INSULIN RELEASE
FRON VESICLES.
22. ION CHANNEL-ROC-EXCITATORY
Ach Nicotinic NN receptor
• CNS, GANGLIA AND
NMJ(NM)
• PENTAMERIC 2 ,β,¥,θ
IN NMJ (NM ) whereas
2ɑ,3β in GANGLIA (NN)
• EACH SUBUNIT HAS 4
HELIXES
• EACH ɑ SUBUNIT HAS
Ach BINDING SITE
23. ION CHANNEL-ROC-EXCITATORY
Glutamate Receptor
• THEY ARE 5 IN NUMBER
• 3 IONOTROPHIC- NMDA
AMPA
KAINATE
• AP-4: INHIBITORY AUTO
RECEPTOR
ACPD: Metabotrophic Gq
AMPA & KAINATE- NON
NMDA RECEPTORS.
30. • SERINE-THREONINE
KINASES AT THE
CYTOPLASMIC DOMAIN
INSTEAD OF RTK.
• eg: TGF-β
• TYPE 1- 7 ISOFORMS
• TYPE 2- 5 FORMS
• SMAD PROTEINS
• INHIBITORY SMADS-6
AND 7.
31. TOLL-LIKE RECEPTORS
• INNATE IMMUNE SYSYTEM-
HAEMPOIETIC CELLS
• INTRACELLULAR DOMAIN IS
TIR DOMAIN
• LIGANDS- LIPIDS,
PEPTIDOGLYCANS,
LIPOPEPTIDES AND
VIRUSES.
• TNF-ɑ: TYPE 1, 2
• TRIMERIZATION- DEATH
DOMAIN is IC domain.
32. cGMP Receptors
• Guanylate cyclase is
transmembrane here
• ligands- ANP, NO
• Intracellular domain - GC
domain
• NO stimulates GC
→cGMP produced.
• EFFECTS: BP↓ , reduces
cardiac hypertrophy &
fibrosis.
33. Nuclear hormone Receptors
• cytosolic- steroids and sex
hormones
• Nuclear -TR, PPAR,
RXR,LXR,FXR, vitamin A & D
Receptors.
• heterodimers. slow & long
lasting process.
34. • Time for Gene Transcription:
• GPCR : Few sec to min
• Ion channels: milli seconds
• Tyrosine kinase :minutes
• nuclear: longer time
37. Regulation of receptors
• Receptor Desensitisation:Receptor mediated
response after initial high level, gradually
diminishes even in continuing presence of agonist.
• Down regulation: Prolonged exposure to high
concentration of agonist causes reduction in
number of receptors available for activation
• Up regulation:Prolonged occupation of receptors
by a antagonist leads to increase in number of
receptors-receptor sensitivity increases
• Denervation Supersensitivity: In Denervated
muscles, proliferation of new dopamine receptors
eg: tardive dyskinesia